Q2 2025 saw 2.5% revenue growth and 6.8% gross profit increase, with margin expansion driven by contract renegotiations and strong retail and vaccine performance. Leverage improved to 4.33x, and cash generation remains a key focus for H2.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.